Works by JABBOUR, ELIAS


Results: 606
    1
    2
    3
    4
    5
    6
    7

    Helium anion formation inside helium droplets.

    Published in:
    European Physical Journal D (EPJ D), 2016, v. 70, n. 7, p. 1, doi. 10.1140/epjd/e2016-70136-3
    By:
    • Jabbour Al Maalouf, Elias;
    • Reitshammer, Julia;
    • Ribar, Anita;
    • Scheier, Paul;
    • Denifl, Stephan
    Publication type:
    Article
    8
    9
    10

    Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis.

    Published in:
    Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01630-w
    By:
    • Urrutia, Samuel;
    • Kantarjian, Hagop M.;
    • Ravandi-Kashani, Farhad;
    • Bueso-Ramos, Carlos;
    • Kanagal-Shamanna, Rashmi;
    • Jabbour, Elias;
    • Montalban-Bravo, Guillermo;
    • Short, Nicholas J.;
    • Daver, Naval;
    • Borthakur, Gautam;
    • Dinardo, Courtney D.;
    • Kadia, Tapan M.;
    • Masarova, Lucia;
    • Bose, Prithviraj;
    • Pemmaraju, Naveen;
    • Garcia-Manero, Guillermo;
    • Sasaki, Koji
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Initial Report of a Phase I Study of LY2510924, Idarubicin, and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia.

    Published in:
    Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00369
    By:
    • Boddu, Prajwal;
    • Borthakur, Gautam;
    • Koneru, Mythili;
    • Huang, Xuelin;
    • Naqvi, Kiran;
    • Wierda, William;
    • Bose, Prithviraj;
    • Jabbour, Elias;
    • Estrov, Zeev;
    • Burger, Jan;
    • Alvarado, Yesid;
    • Dekmush, April;
    • Patel, Ami;
    • Cavazos, Antonio;
    • Han, Lina;
    • Cortes, Jorge E.;
    • Kantarjian, Hagop;
    • Andreeff, Michael;
    • Konopleva, Marina
    Publication type:
    Article
    21
    22
    23
    24

    Chronic Myeloid Leukemia: A Review.

    Published in:
    JAMA: Journal of the American Medical Association, 2025, v. 333, n. 18, p. 1618, doi. 10.1001/jama.2025.0220
    By:
    • Jabbour, Elias;
    • Kantarjian, Hagop
    Publication type:
    Article
    25

    Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2024, v. 331, n. 21, p. 1814, doi. 10.1001/jama.2024.4783
    By:
    • Jabbour, Elias;
    • Kantarjian, Hagop M.;
    • Aldoss, Ibrahim;
    • Montesinos, Pau;
    • Leonard, Jessica T.;
    • Gómez-Almaguer, David;
    • Baer, Maria R.;
    • Gambacorti-Passerini, Carlo;
    • McCloskey, James;
    • Minami, Yosuke;
    • Papayannidis, Cristina;
    • Rocha, Vanderson;
    • Rousselot, Philippe;
    • Vachhani, Pankit;
    • Wang, Eunice S.;
    • Wang, Bingxia;
    • Hennessy, Meliessa;
    • Vorog, Alexander;
    • Patel, Niti;
    • Yeh, Tammie
    Publication type:
    Article
    26
    27

    Inotuzumab ozogamicin in combination with low‐intensity chemotherapy (mini‐HCVD) with or without blinatumomab versus standard intensive chemotherapy (HCVAD) as frontline therapy for older patients with Philadelphia chromosome‐negative acute lymphoblastic leukemia: A propensity score analysis

    Published in:
    Cancer (0008543X), 2019, v. 125, n. 15, p. 2579, doi. 10.1002/cncr.32139
    By:
    • Jabbour, Elias J.;
    • Sasaki, Koji;
    • Ravandi, Farhad;
    • Short, Nicholas J.;
    • Garcia‐Manero, Guillermo;
    • Daver, Naval;
    • Kadia, Tapan;
    • Konopleva, Marina;
    • Jain, Nitin;
    • Cortes, Jorge;
    • Issa, Ghayas C.;
    • Jacob, Jovitta;
    • Kwari, Monica;
    • Thompson, Philip;
    • Garris, Rebecca;
    • Pemmaraju, Naveen;
    • Yilmaz, Musa;
    • O'Brien, Susan M.;
    • Kantarjian, Hagop M.
    Publication type:
    Article
    28
    29

    Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome.

    Published in:
    2019
    By:
    • Naqvi, Kiran;
    • Sasaki, Koji;
    • Montalban‐Bravo, Guillermo;
    • Alfonso Pierola, Ana;
    • Yilmaz, Musa;
    • Short, Nicholas;
    • Assi, Rita;
    • Jabbour, Elias;
    • Ravandi, Farhad;
    • Kadia, Tapan;
    • Pierce, Sherry;
    • Takahashi, Koichi;
    • Nogueras Gonzalez, Graciela;
    • Kanagal‐Shamanna, Rashmi;
    • Patel, Keyur;
    • Soltysiak, Kelly A.;
    • Kantarjian, Hagop M.;
    • Garcia‐Manero, Guillermo;
    • Montalban-Bravo, Guillermo;
    • Kanagal-Shamanna, Rashmi
    Publication type:
    journal article
    30
    31

    The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia.

    Published in:
    2019
    By:
    • Williams, Patrick;
    • Basu, Sreyashi;
    • Garcia‐Manero, Guillermo;
    • Hourigan, Christopher S.;
    • Oetjen, Karolyn A.;
    • Cortes, Jorge E.;
    • Ravandi, Farhad;
    • Jabbour, Elias J.;
    • Al‐Hamal, Zainab;
    • Konopleva, Marina;
    • Ning, Jing;
    • Xiao, Lianchun;
    • Hidalgo Lopez, Juliana;
    • Kornblau, Steve M.;
    • Andreeff, Michael;
    • Flores, Wilmer;
    • Bueso‐Ramos, Carlos;
    • Blando, Jorge;
    • Galera, Pallavi;
    • Calvo, Katherine R.
    Publication type:
    journal article
    32

    Inotuzumab ozogamicin in combination with low-intensity chemotherapy (mini-HCVD) with or without blinatumomab versus standard intensive chemotherapy (HCVAD) as frontline therapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis.

    Published in:
    2019
    By:
    • Jabbour, Elias J;
    • Sasaki, Koji;
    • Ravandi, Farhad;
    • Short, Nicholas J;
    • Garcia-Manero, Guillermo;
    • Daver, Naval;
    • Kadia, Tapan;
    • Konopleva, Marina;
    • Jain, Nitin;
    • Cortes, Jorge;
    • Issa, Ghayas C;
    • Jacob, Jovitta;
    • Kwari, Monica;
    • Thompson, Philip;
    • Garris, Rebecca;
    • Pemmaraju, Naveen;
    • Yilmaz, Musa;
    • O'Brien, Susan M;
    • Kantarjian, Hagop M
    Publication type:
    journal article
    33

    Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes.

    Published in:
    2019
    By:
    • Boddu, Prajwal C.;
    • Kadia, Tapan M.;
    • Garcia‐Manero, Guillermo;
    • Cortes, Jorge;
    • Alfayez, Mansour;
    • Borthakur, Gautam;
    • Konopleva, Marina;
    • Jabbour, Elias J.;
    • Daver, Naval G.;
    • DiNardo, Courtney D.;
    • Naqvi, Kiran;
    • Yilmaz, Musa;
    • Short, Nicholas J.;
    • Pierce, Sherry;
    • Kantarjian, Hagop M.;
    • Ravandi, Farhad;
    • Garcia-Manero, Guillermo;
    • Kantarjian, Hagop
    Publication type:
    journal article
    34
    35

    Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage.

    Published in:
    2018
    By:
    • Jabbour, Elias;
    • Sasaki, Koji;
    • Ravandi, Farhad;
    • Huang, Xuelin;
    • Short, Nicholas J.;
    • Khouri, Maria;
    • Kebriaei, Partow;
    • Burger, Jan;
    • Khoury, Joseph;
    • Jorgensen, Jeffrey;
    • Jain, Nitin;
    • Konopleva, Marina;
    • Garcia‐Manero, Guillermo;
    • Kadia, Tapan;
    • Cortes, Jorge;
    • Jacob, Jovitta;
    • Montalbano, Kathryn;
    • Garris, Rebecca;
    • O'Brien, Susan;
    • Kantarjian, Hagop M.
    Publication type:
    journal article
    36

    Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value.

    Published in:
    2018
    By:
    • Hidalgo‐Lόpez, Juliana E.;
    • Kanagal‐Shamanna, Rashmi;
    • Quesada, Andrés E.;
    • Gong, Zimu;
    • Wang, Wei;
    • Hu, Shimin;
    • Medeiros, L. Jeffrey;
    • Bassett, Roland L.;
    • d'Orcy, Elizabeth;
    • Yin, C. Cameron;
    • Cortes, Jorge;
    • Jabbour, Elias J.;
    • Kantarjian, Hagop M.;
    • Bueso‐Ramos, Carlos E.;
    • Hidalgo-Lόpez, Juliana E;
    • Kanagal-Shamanna, Rashmi;
    • Bassett, Roland L Jr;
    • Bueso-Ramos, Carlos E
    Publication type:
    journal article
    37
    38
    39

    Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000.

    Published in:
    2018
    By:
    • Kantarjian, Hagop M.;
    • DiNardo, Courtney D.;
    • Nogueras‐Gonzalez, Graciela M.;
    • Kadia, Tapan M.;
    • Jabbour, Elias;
    • Bueso‐Ramos, Carlos E.;
    • O'Brien, Susan M.;
    • Konopleva, Marina;
    • Jain, Nitin B.;
    • Daver, Naval G.;
    • Shpall, Elizabeth J.;
    • Champlin, Richard E.;
    • Simkins, Aron;
    • Garcia‐Manero, Guillermo;
    • Keating, Michael J.;
    • Huang, Xuelin;
    • Cortes, Jorge E.;
    • Pierce, Sherry A.;
    • Ravandi, Farhad;
    • Freireich, Emil J.
    Publication type:
    journal article
    40
    41
    42
    43
    44
    45

    Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies.

    Published in:
    2017
    By:
    • Abaza, Yasmin M.;
    • Kadia, Tapan M.;
    • Jabbour, Elias J.;
    • Konopleva, Marina Y.;
    • Borthakur, Gautam;
    • Ferrajoli, Alessandra;
    • Estrov, Zeev;
    • Wierda, William G.;
    • Alfonso, Ana;
    • Chong, Toh Han;
    • Chuah, Charles;
    • Koh, Liang‐Piu;
    • Goh, Boon‐Cher;
    • Chang, Julie E.;
    • Durkes, Daniel E.;
    • Foudray, Maria Cielo;
    • Kantarjian, Hagop M.;
    • Dong, Xiao Qin;
    • Garcia‐Manero, Guillermo;
    • Koh, Liang-Piu
    Publication type:
    journal article
    46

    Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.

    Published in:
    2017
    By:
    • Jain, Preetesh;
    • Kantarjian, Hagop M.;
    • Ghorab, Ahmad;
    • Sasaki, Koji;
    • Jabbour, Elias J.;
    • Nogueras Gonzalez, Graciela;
    • Kanagal‐Shamanna, Rashmi;
    • Issa, Ghayas C.;
    • Garcia‐Manero, Guillermo;
    • KC, Devendra;
    • Dellasala, Sara;
    • Pierce, Sherry;
    • Konopleva, Marina;
    • Wierda, William G.;
    • Verstovsek, Srdan;
    • Daver, Naval G.;
    • Kadia, Tapan M.;
    • Borthakur, Gautam;
    • O'Brien, Susan;
    • Estrov, Zeev
    Publication type:
    journal article
    47

    A randomized phase 2 study of idarubicin and cytarabine with clofarabine or fludarabine in patients with newly diagnosed acute myeloid leukemia.

    Published in:
    2017
    By:
    • Jabbour, Elias;
    • Short, Nicholas J.;
    • Ravandi, Farhad;
    • Huang, Xuelin;
    • Xiao, Lianchun;
    • Garcia‐Manero, Guillermo;
    • Plunkett, William;
    • Gandhi, Varsha;
    • Sasaki, Koji;
    • Pemmaraju, Naveen;
    • Daver, Naval G.;
    • Borthakur, Gautam;
    • Jain, Nitin;
    • Konopleva, Marina;
    • Estrov, Zeev;
    • Kadia, Tapan M.;
    • Wierda, William G.;
    • DiNardo, Courtney D.;
    • Brandt, Mark;
    • O'Brien, Susan M.
    Publication type:
    journal article
    48
    49
    50

    Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes.

    Published in:
    2017
    By:
    • Garcia-Manero, Guillermo;
    • Montalban-Bravo, Guillermo;
    • Berdeja, Jesus G.;
    • Abaza, Yasmin;
    • Jabbour, Elias;
    • Essell, James;
    • Lyons, Roger M.;
    • Ravandi, Farhad;
    • Maris, Michael;
    • Heller, Brian;
    • DeZern, Amy E.;
    • Babu, Sunil;
    • Wright, David;
    • Anz, Bertrand;
    • Boccia, Ralph;
    • Komrokji, Rami S.;
    • Kuriakose, Philip;
    • Reeves, James;
    • Sekeres, Mikkael A.;
    • Kantarjian, Hagop M.
    Publication type:
    journal article